Life & LuxuryArts & CultureAFR MagazinePrint articleNobel Prize winner Peter Doherty reveals his pandemic page-turnersLuke SlatteryMay 22, 2020 – 11.05amSaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginPeter Doherty, medical researcher, Nobel prize winner and author, sits down with The Australian Financial Review Magazine for this month’s What I Am Reading column.Our June issue is out on May 29 inside the Financial Review.Loading...SaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLicense articleIntroducing your NewsfeedFollow the topics, people and companies that matter to you.Find out moreRead MoreAFR MagazineWhat I Am ReadingLiteratureRevieweBooksScienceNobel PrizeCoronavirus pandemicResearchPeter DohertyLatest In Arts & CultureFetching latest articlesMost Viewed In Life and luxuryThe Australian Financial Review MagazineSports stars keep shifting their watch brand allegiancesBani McSpeddenDark Emu beer with native grains at this destination breweryCrocs turn 23 years old. Time to grow up and get shoesBOSS Financial ReviewFour women who started businesses after the age of 45Sally PattenWhat happened when Domain learnt it spent $36m a year on meetingsThe country’s highest-paid directors revealedLife & LeisureA backyard beehive and an on-trend merino sweater to wear this winter1 hr agoEugenie KellyWill BMW’s Neue Klasse range be the game-changing EVs they promise?The Australian gallery that made art fun turns 20Rich ListProperty billionaire Nick Andrianakos dies in GreeceYolanda RedrupCannon-Brookes describes ‘deep internal conflict’ over his private jetOscar Piastri on the secret of his $41m-a year success